| Literature DB >> 34195067 |
Abstract
PURPOSE: The categorization of inventories using various techniques optimizes the efficiency of warehouse operations. The ABC (always, better, and control); VED (vital, essential, and desirable); and FNS (fast-, normal-, and slow-moving) analyses provide items according to cost significance, criticality value, and consumption rate respectively. Thus, this study aimed to identify the categories of items requiring focused managerial control, priority, and replenishment intervals, as well as to evaluate whether the ABC-VED-FNS matrix is fit for effective and efficient inventory control of the Ethiopian Pharmaceutical Supply Agency (EPSA).Entities:
Keywords: ABC–VED–FNS matrix analysis; Ethiopian pharmaceuticals supply agency; operational efficiency; pharmaceuticals inventory management
Year: 2021 PMID: 34195067 PMCID: PMC8238545 DOI: 10.2147/IPRP.S310716
Source DB: PubMed Journal: Integr Pharm Res Pract ISSN: 2230-5254
Figure 1ABC analysis by cumulative curve, 2020 (N = 393 items).
ABC, and VED Analysis and ABC-VED Matrix Analysis of the EPSA Pharmaceuticals (N = 393)
| ABC/VED Matrix | Class “A” | Class “B” | Class “C” | Total | ||||
|---|---|---|---|---|---|---|---|---|
| Items (%) | ASV (%) | Items (%) | ASV (%) | Items (%) | ASV (%) | Items (%) | ASV (%) | |
| 36 (9%) | 63% | 42 (11%) | 8% | 87 (22%) | 2% | 42% | 73% | |
| 22 (6%) | 17% | 30 (8%) | 5% | 142 (36%) | 3% | 49% | 25% | |
| 0 | 0 | 6 (2%) | 1% | 28 (7%) | 1% | 9% | 2% | |
| 58(15%) | 80% | 78 (20%) | 14% | 257 (65%) | 6% | 100% | 100% | |
| 58 (15%) | 80% | 42 (11%) | 8% | 87 (22%) | 2% | 47.58% | 90% | |
| 0 | 0 | 36 (10%) | 6% | 142 (36%) | 3% | 45.29% | 9% | |
| 0 | 0 | 0 | 0 | 28 (65%) | 1% | 7.13% | 1% | |
FNS Analysis of Pharmaceuticals in the Study Area, 2020 (N = 393)
| FNS Category | Total No of Items (%) | Annual Sales Value (ASV) |
|---|---|---|
| Fast-moving (F) | 60 (15.30%) | 73.10% |
| Normal-moving (N) | 112 (28.50%) | 20.30% |
| Slow-moving (S) | 221 (56.20%) | 6.60% |
| 393 (100%) | 100% |
ABC, VED, and FNS Analysis and ABC–VED–FNS Matrix Analysis in the Study Area (N = 393)
| ABC-VED | AV | AE | AD | BV | CV | BE | BD | CE | CD | Total No of Items (%) | ASV |
|---|---|---|---|---|---|---|---|---|---|---|---|
| F | 29 | 10 | 0 | 8 | 4 | 7 | 0 | 2 | 0 | 60 (15.3%) | 73.1% |
| N | 6 | 11 | 0 | 23 | 17 | 19 | 4 | 28 | 4 | 112 (28.5%) | 20.3% |
| S | 1 | 1 | 0 | 11 | 66 | 4 | 2 | 112 | 24 | 221 (56.2%) | 6.6% |
| 36 | 22 | 0 | 42 | 87 | 30 | 6 | 142 | 28 | 393 (100%) | 100% | |
| 187 (47.58%)* | 178 (45.29%) ** | 28 (7.13%)*** | |||||||||
Notes: *Category I. **Category II. ***Category III).
Top-Ten “AVF” Pharmaceuticals from ABC–VED–FNS Matrix Analysis in the Study Area (N = 393)
| S. No | Item Details | Unit | 2019/20 Issue Quantity | AMC | Issue Count | Total Cost | VED Category | ABC Group | FNS Group | ABC–VED–FNS Matrix |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Ceftriaxone - 1g in vial - Powder for Injection with 10mL Diluent | Each | 458,508 | 35,077 | 838 | 4,071,555 | V | A | F | AVF |
| 2 | Syringe (Disposable) - 5mL with Needle21G | 100 | 42,574 | 4258 | 819 | 6,775,917 | V | A | F | AVF |
| 3 | Glove Surgical Latex Powder -Free Sterile -No.7.5 | 50 pairs | 71,650 | 7165 | 711 | 13,321,696 | V | A | F | AVF |
| 4 | Diclofenac Sodium - 25mg/mL in 3mL ampoule - Injection | 10x10 | 16,082 | 1828 | 675 | 1,547,096 | V | A | F | AVF |
| 5 | Sodium Chloride (Normal Saline) - 0.009 - Intravenous Infusion with Giving Set | 1000 mL | 165,214 | 16,521 | 652 | 3,979,592 | V | A | F | AVF |
| 6 | Ciprofloxacin - 500mg – Tablet | 10x10 | 27,841 | 3381 | 459 | 2,029,081 | V | A | F | AVF |
| 7 | Doxycycline - 100mg – Capsule | 20x10 | 20,644 | 3209 | 640 | 2,137,810 | E | A | F | AEF |
| 8 | Amoxicillin - 500mg – Capsule | 50x10 | 10,672 | 1404 | 482 | 4,297,864 | V | A | F | AVF |
| 9 | Cloxacillin Sodium - 500 mg – Capsule | 50x10 | 12,745 | 1275 | 675 | 6,775,917 | V | A | F | AVF |
| 10 | Syringe (Disposable) - 10mL with Needle21G | 100 | 26,424 | 1039 | 620 | 2,073,649 | V | A | F | AVF |